BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 15710226)

  • 21. [Budesonide in treatment of patients with cross primary biliary cirrhosis and autoimmune hepatitis].
    Golovanova EV; Khomeriki SG; Petrakov AV; Serova TI
    Eksp Klin Gastroenterol; 2010; (8):113-7. PubMed ID: 21268335
    [No Abstract]   [Full Text] [Related]  

  • 22. Reflections on therapeutic trials in primary biliary cirrhosis: a quality of life oriented counter-view.
    Jones DE; Bhala N; Newton JL
    Hepatology; 2006 Mar; 43(3):633; author reply 634. PubMed ID: 16496315
    [No Abstract]   [Full Text] [Related]  

  • 23. [Intrahepatic cholestasis of pregnancy treated with ursodeoxycholic acid. Results from a two-year survey at Rigshospitalet, Skejby Hospital and Odense University Hospital].
    Jochumsen KM; Svane D; Bødker B; Skajaa K; Westergaard JG
    Ugeskr Laeger; 2003 Sep; 165(40):3825-8. PubMed ID: 14560505
    [No Abstract]   [Full Text] [Related]  

  • 24. [Efficacy of combined use of ursodeoxycholic acid and heptral in the treatment of primary biliary cirrhosis].
    Avezov SA; Mansurova FKh
    Klin Med (Mosk); 2004; 82(2):46-9. PubMed ID: 15106512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fenofibrate treatment in patients with primary biliary cirrhosis.
    Ohira H; Sato Y; Ueno T; Sata M
    Am J Gastroenterol; 2002 Aug; 97(8):2147-9. PubMed ID: 12190200
    [No Abstract]   [Full Text] [Related]  

  • 26. Ursodeoxycholic acid reduces increased circulating endothelin 2 in primary biliary cirrhosis.
    Dimoulios P; Kolios G; Notas G; Matrella E; Xidakis C; Koulentaki M; Tsagarakis N; Kouroumalis A; Kouroumalis E
    Aliment Pharmacol Ther; 2005 Feb; 21(3):227-34. PubMed ID: 15691296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre.
    Floreani A; Caroli D; Variola A; Rizzotto ER; Antoniazzi S; Chiaramonte M; Cazzagon N; Brombin C; Salmaso L; Baldo V
    Liver Int; 2011 Mar; 31(3):361-8. PubMed ID: 21059170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of primary biliary cirrhosis].
    Szalay F
    Orv Hetil; 2003 Sep; 144(36):1787-8. PubMed ID: 14579676
    [No Abstract]   [Full Text] [Related]  

  • 29. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy. A retrospective study of 19 cases.
    Berkane N; Cocheton JJ; Brehier D; Merviel P; Wolf C; Lefèvre G; Uzan S
    Acta Obstet Gynecol Scand; 2000 Nov; 79(11):941-6. PubMed ID: 11081677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of primary biliary cirrhosis: therapy with choleretic and immunosuppressive agents.
    Silveira MG; Lindor KD
    Clin Liver Dis; 2008 May; 12(2):425-43; x-xi. PubMed ID: 18456189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ursodeoxycholic acid: a second look. Primary biliary cirrhosis: dashed hopes.
    Prescrire Int; 2002 Jun; 11(59):67-9. PubMed ID: 12068838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ursodeoxycholic acid for primary biliary cirrhosis: lesson for the future?
    Gluud C; Christensen E
    J Hepatol; 2001 May; 34(5):787-8. PubMed ID: 11434634
    [No Abstract]   [Full Text] [Related]  

  • 33. [Medical treatment of chronic cholestasis: ursodeoxycholic acid].
    Linares Rodríguez A
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():24-38. PubMed ID: 11968340
    [No Abstract]   [Full Text] [Related]  

  • 34. The timing of liver transplantation in primary biliary cirrhosis.
    Angulo P; Dickson ER
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):657-68. PubMed ID: 10976021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Good prognosis in asymptomatic primary biliary cirrhosis].
    Lööf L; Lindgren S
    Lakartidningen; 2010 May 26-Jun 1; 107(21):1396-8. PubMed ID: 20645617
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy.
    Kondrackiene J; Beuers U; Kupcinskas L
    Gastroenterology; 2005 Sep; 129(3):894-901. PubMed ID: 16143129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary biliary cirrhosis.
    Kaplan MM; Gershwin ME
    N Engl J Med; 2005 Sep; 353(12):1261-73. PubMed ID: 16177252
    [No Abstract]   [Full Text] [Related]  

  • 38. Ursodeoxycholic acid for primary biliary cirrhosis: treat early to slow progression.
    Paumgartner G
    J Hepatol; 2003 Jul; 39(1):112-4. PubMed ID: 12821052
    [No Abstract]   [Full Text] [Related]  

  • 39. Ursodeoxycholic acid for primary biliary cirrhosis: lessons from the past--issues for the future.
    Poupon RE
    J Hepatol; 2000 Apr; 32(4):685-8. PubMed ID: 10782919
    [No Abstract]   [Full Text] [Related]  

  • 40. [Autoimmune cholestasis syndrome. Ursodeoxycholic acid is the drug standard].
    Stiefelhagen P
    MMW Fortschr Med; 2007 May; 149(21):49. PubMed ID: 17668736
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.